Craig McAndrew

998 total citations
21 papers, 527 citations indexed

About

Craig McAndrew is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Craig McAndrew has authored 21 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Craig McAndrew's work include Protein Degradation and Inhibitors (4 papers), Cancer-related Molecular Pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Craig McAndrew is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Cancer-related Molecular Pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Craig McAndrew collaborates with scholars based in United Kingdom, Germany and Sweden. Craig McAndrew's co-authors include Colin R. Goding, F. Fisher, Rosemary Burke, Paul Workman, Ian Collins, Keith Jones, Martin Rowlands, Mark Stubbs, John Caldwell and Amin Mirza and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Craig McAndrew

20 papers receiving 515 citations

Peers

Craig McAndrew
Paul Workman United Kingdom
Yvette Newbatt United Kingdom
Wayland Yeung United States
Komal Jhaveri United States
Levon Halabelian Canada
Alexander Gozman United States
Xiaomin Ni Germany
Audrey Restouin France
Carmen Aguilar‐Gurrieri Spain
J.-P. Marquette France
Paul Workman United Kingdom
Craig McAndrew
Citations per year, relative to Craig McAndrew Craig McAndrew (= 1×) peers Paul Workman

Countries citing papers authored by Craig McAndrew

Since Specialization
Citations

This map shows the geographic impact of Craig McAndrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig McAndrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig McAndrew more than expected).

Fields of papers citing papers by Craig McAndrew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig McAndrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig McAndrew. The network helps show where Craig McAndrew may publish in the future.

Co-authorship network of co-authors of Craig McAndrew

This figure shows the co-authorship network connecting the top 25 collaborators of Craig McAndrew. A scholar is included among the top collaborators of Craig McAndrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig McAndrew. Craig McAndrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutsche, Katrin, Amin Mirza, Theodoros I. Roumeliotis, et al.. (2026). Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028 , an In Vitro Degrader Chemical Probe. Journal of Medicinal Chemistry. 69(2). 1552–1567.
2.
Collie, Gavin W., Michael Carter, Craig McAndrew, et al.. (2024). Specific radiation damage to halogenated inhibitors and ligands in protein–ligand crystal structures. Journal of Applied Crystallography. 57(6). 1951–1965. 1 indexed citations
3.
Liu, Manjuan, Amin Mirza, Craig McAndrew, et al.. (2023). Determination of Ligand-Binding Affinity (Kd) Using Transverse Relaxation Rate (R2) in the Ligand-Observed 1H NMR Experiment and Applications to Fragment-Based Drug Discovery. Journal of Medicinal Chemistry. 66(15). 10617–10627. 11 indexed citations
4.
Matthews, Thomas P., Tatiana McHardy, Giampiero Colombano, et al.. (2023). Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes. Journal of Medicinal Chemistry. 66(4). 2622–2645. 3 indexed citations
5.
6.
McAndrew, Craig, Emma Bentley, Giada Mattiuzzo, et al.. (2021). A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection. Scientific Reports. 11(1). 10617–10617. 24 indexed citations
7.
Felisberto‐Rodrigues, Catarina, Craig McAndrew, Yann‐Vaï Le Bihan, et al.. (2019). Structural and functional characterisation of human RNA helicase DHX8 provides insights into the mechanism of RNA-stimulated ADP release. Biochemical Journal. 476(18). 2521–2543. 11 indexed citations
8.
Clarke, Paul A., Toby Roe, Steve Hobbs, et al.. (2019). Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer. Oncogene. 38(25). 5076–5090. 29 indexed citations
9.
Chessum, N., Swee Y. Sharp, John Caldwell, et al.. (2017). Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766). Journal of Medicinal Chemistry. 61(3). 918–933. 74 indexed citations
10.
Jones, Alan M., Isaac M. Westwood, James Osborne, et al.. (2016). A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms. Scientific Reports. 6(1). 34701–34701. 25 indexed citations
11.
Gurden, Mark D., Isaac M. Westwood, Amir Faisal, et al.. (2015). Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. Cancer Research. 75(16). 3340–3354. 24 indexed citations
12.
Joshi, Amar, Yvette Newbatt, Craig McAndrew, et al.. (2015). Molecular mechanisms of human IRE1 activation through dimerization and ligand binding. Oncotarget. 6(15). 13019–13035. 42 indexed citations
13.
Itzhak, Daniel N., Michael D. Bright, Craig McAndrew, et al.. (2014). Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α. BMC Biochemistry. 15(1). 3–3. 16 indexed citations
14.
Westwood, Isaac M., Kathy Boxall, Nathan Brown, et al.. (2013). Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2. PLoS ONE. 8(6). e65689–e65689. 12 indexed citations
15.
Couty, S., Isaac M. Westwood, Andrew Kalusa, et al.. (2013). The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. Oncotarget. 4(10). 1647–1661. 17 indexed citations
16.
Hitchin, James R., Julian Blagg, Rosemary Burke, et al.. (2013). Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments. MedChemComm. 4(11). 1513–1513. 50 indexed citations
17.
Newbatt, Yvette, Anthea Hardcastle, Craig McAndrew, et al.. (2012). Identification of Autophosphorylation Inhibitors of the Inositol-Requiring Enzyme 1 Alpha (IRE1α) by High-Throughput Screening Using a DELFIA Assay. SLAS DISCOVERY. 18(3). 298–308. 12 indexed citations
18.
Martin, Nicholas G., Craig McAndrew, Paul D. Eve, & Michelle D. Garrett. (2008). Phosphorylation of cyclin dependent kinase 4 on tyrosine 17 is mediated by Src family kinases. FEBS Journal. 275(12). 3099–3109. 7 indexed citations
19.
McAndrew, Craig, John Svaren, Stephen R. Martin, Wolfram Hörz, & Colin R. Goding. (1998). Requirements for Chromatin Modulation and Transcription Activation by the Pho4 Acidic Activation Domain. Molecular and Cellular Biology. 18(10). 5818–5827. 40 indexed citations
20.
Fisher, F., et al.. (1994). The transcription factor, the Cdk, its cyclin and their regulator: directing the transcriptional response to a nutritional signal.. The EMBO Journal. 13(22). 5410–5420. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Workman Breakdown of academic impact, for papers by Yvette Newbatt Breakdown of academic impact, for papers by Wayland Yeung Breakdown of academic impact, for papers by Komal Jhaveri Breakdown of academic impact, for papers by Levon Halabelian Breakdown of academic impact, for papers by Alexander Gozman Breakdown of academic impact, for papers by Xiaomin Ni Breakdown of academic impact, for papers by Audrey Restouin Breakdown of academic impact, for papers by Carmen Aguilar‐Gurrieri Breakdown of academic impact, for papers by J.-P. Marquette
Rankless by CCL
2026